A SAFETY STUDY OF HUMAN CORD BLOOD DERIVED, CULTURE EXPANDED NATURAL KILLER CELL (PNK-007) INFUSION WITH SUBCUTANEOUS RECOMBINANT HUMAN IL-2 (RHIL-2) IN ADULTS WITH RELAPSED AND/OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML):